Caplacizumab induces fast and durable platelet count responses with improved time to complete remission and recurrence-free survival in patients with acquired thrombotic thrombocytopenic purpura

Caplacizumab induces fast and durable platelet count responses with improved time to complete remission and recurrence-free survival in patients with acquired thrombotic thrombocytopenic purpura

Bibliographic Details
Main Authors:	L. Kaynar, P. Coppo, M. Scully, J. De La Rubia, F. Peyvandi, S. Cataland, J. A. Kremer Hovinga, P. Knoebl, K. Pavenski, J. Minkue Mi Edou, F. Callewaert, R. De Passos Sousa
Format:	Article
Language:	English
Published:	Elsevier 2020-10-01
Series:	Hematology, Transfusion and Cell Therapy
Online Access:	http://www.sciencedirect.com/science/article/pii/S2531137920302431

Similar Items

OUTCOMES OF PATIENTS WITH WORSENING ACQUIRED THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP) DESPITE DAILY THERAPEUTIC PLASMA EXCHANGE IN THE PHASE 3 HERCULES TRIAL
by: M. Scully, et al.
Published: (2020-11-01)

Caplacizumab in adult patients with acquired thrombotic thrombocytopenic purpura
by: Ashley Hanlon, et al.
Published: (2020-02-01)

Caplacizumab as an emerging treatment option for acquired thrombotic thrombocytopenic purpura
by: Elverdi T, et al.
Published: (2019-04-01)

Safety of caplacizumab in patients without documented severe adamts13 deficiency during the hercules study
by: S. Besisik, et al.
Published: (2020-10-01)

Outcomes in 1096 patients with severe thrombotic thrombocytopenic purpura before the Caplacizumab era.
by: Andry Van de Louw, et al.
Published: (2021-01-01)

Post Approval Experience with Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura at a Single Institution
by: Constantine N. Logothetis, et al.
Published: (2021-07-01)

Refractory Auto-Immune Thrombotic Thrombocytopenic Pupura Successfully Treated With Caplacizumab
by: Chloé Mellaza, et al.
Published: (2020-10-01)

Cost-effectiveness analysis of caplacizumab in the new standard of care for immune Thrombotic Thrombocytopenic Purpura in Italy
by: Giovanni Di Minno, et al.
Published: (2021-04-01)

The pathogenesis of thrombotic Thrombocytopenic Purpura
by: Scully, Marie Ann
Published: (2008)

Thrombotic Thrombocytopenic Purpura: Pathophysiology, Diagnosis, and Management
by: Senthil Sukumar, et al.
Published: (2021-02-01)

Management of thrombotic thrombocytopenic purpura: current perspectives
by: Blombery P, et al.
Published: (2014-02-01)

Thrombotic Thrombocytopenic Purpura
by: Nuchanat Nonsee, et al.
Published: (2015-02-01)

Relapse of Immune Thrombotic Thrombocytopenic Purpura Following Vaccination with COVID19 mRNA Vaccine
by: Katerina Pavenski
Published: (2021-07-01)

Long-term Kidney Outcomes in Patients With Acquired Thrombotic Thrombocytopenic Purpura
by: Dustin J. Little, et al.
Published: (2017-11-01)

Thrombotic Thrombocytopenic Purpura and Gemcitabine
by: Pashtoon Murtaza Kasi
Published: (2011-03-01)

Treatment of thrombotic thrombocytopenic purpura
by: Gennadii M. Galstyan, et al.
Published: (2021-06-01)

Diagnosis of thrombotic thrombocytopenic purpura
by: G. M. Galstyan, et al.
Published: (2020-12-01)

Treatment of thrombotic thrombocytopenic purpura
by: Gennadii M. Galstyan, et al.
Published: (2021-07-01)

Thrombotic Thrombocytopenic Purpura Associated with Pazopanib
by: Umer Syed, et al.
Published: (2018-01-01)

SARS-CoV-2 vaccination and immune thrombotic thrombocytopenic purpura
by: Braunstein, E.M, et al.
Published: (2022)

Thrombotic Thrombocytopenic Purpura in Dengue Fever
by: Tze Yuan Tee, et al.
Published: (2021-07-01)

Thrombotic thrombocytopenic purpura: diagnosis and treatment
by: L В Filatov, et al.
Published: (2004-08-01)

Thrombotic thrombocytopenic purpura during pregnancy
by: Antonio Ponzetto, et al.
Published: (2020-01-01)

TREATMENT OF THROMBOTIC THROMBOCYTOPENIC PURPURA – OUREXPERIENCE
by: Matjaž Sever
Published: (2008-04-01)

Campylobacter Jejuni and Thrombotic Thrombocytopenic Purpura
by: Roman Jaeschke, et al.
Published: (1990-01-01)

Thrombotic Thrombocytopenic Purpura Associated with Pneumococcal Sepsis
by: Jeffrey R Schriber, et al.
Published: (1993-01-01)

Understanding the Health Literacy in Patients With Thrombotic Thrombocytopenic Purpura
by: Leydi C. Velasquez Pereira, et al.
Published: (2020-08-01)

Multi-organ involvement assessed by MRI in patients with thrombotic thrombocytopenic purpura
by: McKenna William J, et al.
Published: (2010-01-01)

Treatment of 36 cases of thrombotic thrombocytopenic purpura
by: Suvajdžić-Vuković Nada D., et al.
Published: (2004-01-01)

Thrombotic thrombocytopenic purpura concomitant with autoimmune thyroiditis
by: Ali Bay, et al.
Published: (2011-12-01)

Thrombotic thrombocytopenic purpura in the first trimester of pregnancy
by: Pooja Sikka, et al.
Published: (2013-01-01)

Atypical Thrombotic Thrombocytopenic Purpura Presenting as Stroke
by: Pradeepthi Badugu, et al.
Published: (2019-01-01)

Moxifloxacin (Avelox) Induced Thrombotic Thrombocytopenic Purpura
by: Sikander P. Surana, et al.
Published: (2012-01-01)

Thrombotic thrombocytopenic purpura (a case report).
by: Parikh P, et al.
Published: (1987-04-01)

Adenocarcinoma of the lung presenting as thrombotic thrombocytopenic purpura
by: Ahmed Dirweesh, et al.
Published: (2017-01-01)

THROMBOTIC THROMBOCYTOPENIC PURPURA IN PATIENTS SUFFERING OF CANCER
by: Marjana Glaser
Published: (2002-07-01)

Thrombotic Thrombocytopenic Purpura due to Checkpoint Inhibitors
by: Alexey Youssef, et al.
Published: (2018-01-01)

Pathogenicity of Anti-ADAMTS13 Autoantibodies in Acquired Thrombotic Thrombocytopenic Purpura
by: Mari R. Thomas, et al.
Published: (2015-08-01)

Approach to Management of Thrombotic Thrombocytopenic Purpura at University of Cincinnati
by: N. Abdel Karim, et al.
Published: (2013-01-01)

Immune-mediated thrombotic thrombocytopenic purpura following COVID-19 vaccination
by: Bellal, M., et al.
Published: (2022)

Cannot write session to /tmp/vufind_sessions/sess_99pq1p74qa06hdrspp5vgm0tgu